DK1140933T3 - Fremgangsmåde til fremstilling af N6-substituerede deaza-adenosinderivater - Google Patents
Fremgangsmåde til fremstilling af N6-substituerede deaza-adenosinderivaterInfo
- Publication number
- DK1140933T3 DK1140933T3 DK99966299T DK99966299T DK1140933T3 DK 1140933 T3 DK1140933 T3 DK 1140933T3 DK 99966299 T DK99966299 T DK 99966299T DK 99966299 T DK99966299 T DK 99966299T DK 1140933 T3 DK1140933 T3 DK 1140933T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- adenosine derivatives
- substituted
- deaza
- substituted deaza
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11448698P | 1998-12-31 | 1998-12-31 | |
| US11602899P | 1999-01-15 | 1999-01-15 | |
| EP99966299A EP1140933B1 (en) | 1998-12-31 | 1999-12-15 | Process for preparing n6-substituted deaza-adenosine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1140933T3 true DK1140933T3 (da) | 2004-12-20 |
Family
ID=26812247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99966299T DK1140933T3 (da) | 1998-12-31 | 1999-12-15 | Fremgangsmåde til fremstilling af N6-substituerede deaza-adenosinderivater |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6429315B1 (da) |
| EP (1) | EP1140933B1 (da) |
| JP (1) | JP2002534430A (da) |
| KR (1) | KR20010089751A (da) |
| CN (1) | CN1383427A (da) |
| AT (1) | ATE275565T1 (da) |
| AU (1) | AU2187100A (da) |
| BR (1) | BR9917000A (da) |
| CA (1) | CA2358962A1 (da) |
| DE (1) | DE69920045T2 (da) |
| DK (1) | DK1140933T3 (da) |
| ES (1) | ES2228163T3 (da) |
| HK (1) | HK1040239A1 (da) |
| PT (1) | PT1140933E (da) |
| SI (1) | SI1140933T1 (da) |
| WO (1) | WO2000040584A2 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69920045T2 (de) | 1998-12-31 | 2005-09-29 | Aventis Pharmaceuticals Inc. | Verfahren zur herstellung von n6-substituierten deaza-adenosinderivaten |
| GT200500281A (es) * | 2004-10-22 | 2006-04-24 | Novartis Ag | Compuestos organicos. |
| GB0500785D0 (en) * | 2005-01-14 | 2005-02-23 | Novartis Ag | Organic compounds |
| GB0607944D0 (en) * | 2006-04-21 | 2006-05-31 | Novartis Ag | Organic compounds |
| GB0607948D0 (en) * | 2006-04-21 | 2006-05-31 | Novartis Ag | Organic compounds |
| GB0607953D0 (en) * | 2006-04-21 | 2006-05-31 | Novartis Ag | Organic compounds |
| GB0607950D0 (en) * | 2006-04-21 | 2006-05-31 | Novartis Ag | Organic compounds |
| AR060607A1 (es) | 2006-04-21 | 2008-07-02 | Novartis Ag | Derivados de purina,composiciones farmaceuticas que los contienen, metodo de preparacion y usos en enfermedades obstructivas o inflamatorias de las vias respiratorias. |
| EP1889846A1 (en) | 2006-07-13 | 2008-02-20 | Novartis AG | Purine derivatives as A2a agonists |
| EP1903044A1 (en) * | 2006-09-14 | 2008-03-26 | Novartis AG | Adenosine Derivatives as A2A Receptor Agonists |
| MX2009004991A (es) * | 2006-11-10 | 2009-05-20 | Novartis Ag | Derivados de monoacetato de ciclopenteno-diol. |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5652366A (en) | 1990-09-25 | 1997-07-29 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereof |
| AU654507B2 (en) | 1990-09-25 | 1994-11-10 | Rhone-Poulenc Rorer International (Holdings) Inc. | Compounds having antihypertensive and anti-ischemic properties |
| US5561134A (en) | 1990-09-25 | 1996-10-01 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| US5545769A (en) | 1994-09-29 | 1996-08-13 | E. I. Du Pont De Nemours And Company | Process for the manufacture of selected halogenated hydrocarbons containing fluorine and hydrogen and compositions provided therein |
| US5684159A (en) | 1995-05-30 | 1997-11-04 | Rhone-Poulenc Rorer S.A. | L-tartaric acid salt of a (1R) diastereomer of a 2-azadihydroxybicyclo 2.2.1!heptane compound and the preparation of 2-azabicyclo 2.2.1!heptane compounds |
| FR2734822B1 (fr) | 1995-05-30 | 1997-07-04 | Rhone Poulenc Rorer Sa | Nouveaux derives du 2-azabicyclo(2.2.1)heptane, leur preparation et leur application |
| JP2000502709A (ja) | 1996-01-02 | 2000-03-07 | ローヌ―プーラン ローラー ファーマシューティカルズ インコーポレイテッド | ２，４―ジヒドロキシピリジン及び２，４―ジヒドロキシ―３―ニトロピリジンの製造方法 |
| UA51716C2 (uk) * | 1996-07-08 | 2002-12-16 | Авентіс Фармасьютікалз Продактс Інк. | Сполуки, що мають гіпотензивну, кардіопротекторну, анти-ішемічну та антиліполітичну властивості, фармацевтична композиція та способи лікування |
| CA2265886A1 (en) | 1996-09-12 | 1998-03-19 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Stereospecific preparation of chiral 1-aryl- and 1-heteroaryl-2-substituted ethyl-2-amines |
| ATE301120T1 (de) | 1996-12-11 | 2005-08-15 | Aventis Pharma Inc | Herstellung von (1s-(1a,2b,3b,4(s*)))-4-(7-((1-(3-chlor-2-thien l)methyl)propyl)amino)-3h-imidazo(4,5-b)pyridin 3-yl)-n-ethyl-2,3- dihydroxycyclopentancarboxamid |
| DE69920045T2 (de) | 1998-12-31 | 2005-09-29 | Aventis Pharmaceuticals Inc. | Verfahren zur herstellung von n6-substituierten deaza-adenosinderivaten |
-
1999
- 1999-12-15 DE DE69920045T patent/DE69920045T2/de not_active Expired - Fee Related
- 1999-12-15 JP JP2000592292A patent/JP2002534430A/ja active Pending
- 1999-12-15 CN CN99815953A patent/CN1383427A/zh active Pending
- 1999-12-15 WO PCT/US1999/029841 patent/WO2000040584A2/en not_active Application Discontinuation
- 1999-12-15 CA CA002358962A patent/CA2358962A1/en not_active Abandoned
- 1999-12-15 SI SI9930688T patent/SI1140933T1/xx unknown
- 1999-12-15 DK DK99966299T patent/DK1140933T3/da active
- 1999-12-15 BR BR9917000-0A patent/BR9917000A/pt not_active IP Right Cessation
- 1999-12-15 AU AU21871/00A patent/AU2187100A/en not_active Abandoned
- 1999-12-15 KR KR1020017008416A patent/KR20010089751A/ko not_active Application Discontinuation
- 1999-12-15 AT AT99966299T patent/ATE275565T1/de not_active IP Right Cessation
- 1999-12-15 ES ES99966299T patent/ES2228163T3/es not_active Expired - Lifetime
- 1999-12-15 EP EP99966299A patent/EP1140933B1/en not_active Expired - Lifetime
- 1999-12-15 PT PT99966299T patent/PT1140933E/pt unknown
-
2000
- 2000-01-21 US US09/489,276 patent/US6429315B1/en not_active Expired - Fee Related
-
2001
- 2001-11-05 HK HK01107707A patent/HK1040239A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1140933B1 (en) | 2004-09-08 |
| EP1140933A2 (en) | 2001-10-10 |
| CN1383427A (zh) | 2002-12-04 |
| JP2002534430A (ja) | 2002-10-15 |
| KR20010089751A (ko) | 2001-10-08 |
| AU2187100A (en) | 2000-07-24 |
| HK1040239A1 (en) | 2002-05-31 |
| WO2000040584A2 (en) | 2000-07-13 |
| ATE275565T1 (de) | 2004-09-15 |
| WO2000040584A3 (en) | 2000-11-02 |
| DE69920045T2 (de) | 2005-09-29 |
| SI1140933T1 (en) | 2005-02-28 |
| ES2228163T3 (es) | 2005-04-01 |
| US6429315B1 (en) | 2002-08-06 |
| PT1140933E (pt) | 2004-12-31 |
| CA2358962A1 (en) | 2000-07-13 |
| DE69920045D1 (de) | 2004-10-14 |
| BR9917000A (pt) | 2001-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1040108E (pt) | Derivados de orto-antranilamida como anticoagulantes | |
| ES2195163T3 (es) | Derivados de pirimidina biciclicos y su uso como anticoagulantes. | |
| LT2001061A (en) | Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants | |
| DK1040107T3 (da) | 6-O-alkyl-derivater af erythronolid B | |
| ATE274348T1 (de) | Überbrückte indenopyrrolocarbazole | |
| DK1015466T3 (da) | Derivater af 9-hydrazon og 9-azinerythromycin og en fremgangsmåde til fremstilling af samme | |
| DK1140933T3 (da) | Fremgangsmåde til fremstilling af N6-substituerede deaza-adenosinderivater | |
| DK1068209T3 (da) | Fremgangsmåde til fremstilling af purinderivater og deres mellemprodukter | |
| DK1206452T3 (da) | Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser | |
| DK0927766T3 (da) | Enzymatisk fremgangsmåde til fremstilling af (S)-cyanhydriner | |
| DK1307436T3 (da) | Fremgangsmåde til fremstilling af baccatin III-derivater | |
| DE69703115T2 (de) | Zwischenprodukte um 2-imidazolin-5onederivate herzustellen. | |
| YU51401A (sh) | Postupak za dobijanje n6-supstituisanih derivata deaza-adenozima | |
| DK1001929T3 (da) | Fremgangsmåde til fremstilling af 3-cyano-2,4-dihalogen-5-flour-benzoesyrer | |
| CY1109583T1 (el) | Κυτοκινες θηλαστικων, αντιστοιχα αντιδραστηρια | |
| DK0981950T3 (da) | Fremgangsm,åde til formering af phyllocactus | |
| DK0817784T3 (da) | Fremgangsmåde til syntese af nucleosidanaloger | |
| DK0934256T3 (da) | Fremgangsmåde til fremstilling af cyanocinnamamider | |
| DK0961770T3 (da) | Fremgangsmåder til fremstilling af 3-cyanopyridin ud fra 2-methyl-1,5-pentandiamin | |
| EA200000705A1 (ru) | Промежуточные соединения и способ синтеза 17-замещенных 16.бета.-арилокси 4-азастероидов | |
| DK1104415T3 (da) | Fremgangsmåde til fremstilling af 1,3-oxathiolan-nukleosider | |
| ECSP003511A (es) | Procedimiento para preparar derivados de 10,11-metanobenzosuberano | |
| DK0882050T3 (da) | Fremgangsmåde til fremstilling af purinderivater |